TrialBreast cancer research : BCR2014

Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer.

Edith A Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.